Floatz logo

Simethicone

Chronic Kidney Disease

Alfredo Di LeoUNKNOWNPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

30 Active assets in the Chronic Kidney Disease cohort.

Asset / SponsorPhaseRating
SODIUM FERRIC GLUCONATE
Watson Pharmaceuticals
Phase 4BBB
Semaglutide
Institute of Liver and Biliary Sciences, India
Phase 4BBB
Iron(Ii) Sulphate (1:1), Heptahydrate
Watson Pharmaceuticals
Phase 4BBB
CLOPIDOGREL
Hospital Alemão Oswaldo Cruz
Phase 4BB
Aspirin
Hospital Alemão Oswaldo Cruz
Phase 4BB

View all 50 →

Same molecule, other indications

Simethicone is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative · Phase 4
65 / 100
View asset →
polyp of colonDormant
BB
Indicative · Phase 4
65 / 100
View asset →
colon carcinomaDormant
B
Indicative · Phase 4
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →